Page 40 - P4304.1-V92_PS-Magazine-December 2023 PRINT

PSUK
Shred-it and PSUK,
working together.
Security of patient information is critical.
GDPR legislation applies to any business and
organisation anywhere in the world which
processes information about EU citizens.
Any business or organisation failing to comply
with this legislation could incur a fine of
up to £20 million or 4% of global turnover,
whichever is greater, dependent on the nature
of the offence.
To comply with the GDPR, businesses
must implement appropriate technical and
organisational measures that not only ensure
that they comply with the GDPR legislation;
they also need to be able to demonstrate
compliance. A provider like Shred-it can help
you do this.
Together, PSUK and Shred-it are partners
offering reduced rates for PSUK sites. Shred-
it has been providing secure information
destruction services to over 400,000
customers since 1988 and help you meet
your compliance and GPDR obligations with
reliable, on-time service. Whether it’s a clear
out of archived materials or regularly scheduled
service, we help you prevent confidential
information from ending up in the wrong hands.
Benefits of using Shred-it:
• A cost-effective way of meeting
compliance obligations with a reduced rate
already negotiated for PSUK customers
• Secure Chain of Custody: vetted
staff, barcode scanning, Certificate of
Destruction and Waste Transfer Notes
®
Shred-it is a Stericycle solution.
Corner House · 177 Cross Street · Sale · Manchester · M33 7JQ
T: 0800 028 1164 · shredit.co.uk
Shred-it Ltd. Registered in England and Wales No. 04047194 · Registered office: Comer House, 177 Cross Street, Sale, Manchester, M33 7JQ
40 PS Magazine | Shred-it
P4304.1-V92_PS-Magazine-December 2023.indd 40
P4304.1-V92_PS-Magazine-December 2023.indd 40
We protect what matters.
• FREE Data Security Survey to assess your
needs and areas of risk
• Both on and offsite destruction options
• Free of charge rental of secure containers in
a variety of sizes
• A non-intrusive service that frees up staff
members’ time who previously shredded
documents themselves
• All paper put in to the Shred-it security
consoles is recycled. Fill a console twice and
save one tree through recycling, helping to
reduce your carbon footprint
• Annual Trees Saved Certificate (upon
request) to show environmental impact of
your shredding efforts.
Did you know… as well as the destruction of
paper, Shred-it also destroy other items such
as hard drives, x-ray film, uniforms, media
(floppy disks, CDs, tapes), branded literature,
brochures and business cards.
For more information or to take advantage of
the PSUK rates please email:
Ruth.Phillips@stericycle.com
REDUCED PSUK RATES:
Off-site shredding -
£9.45 per console, £3.78 per archive box or
white bag. £37.80 minimum charge.
On-site shredding -
£10.50 per console, £4.20 per archive box
or white bag. £42.00 minimum charge.
Buy direct online at PSUK.co.uk
09/11/2023
09/11/2023
OFFER
A simple choice
for bone health...
Maximising your savings with Accrete-D !
3
Accrete-D3 Film-coated Tablets Accrete-D3 One-a-Day Chewable Tablets
Pack Size: 60 Pack Size: 30
PIP Code: 366-8969 PIP Code: 405-6008
NHS Price: £2.95 NHS Price: £2.95
Net Price: £2.36 Net Price: £2.36
PROFIT: £0.59 PROFIT: £0.59
PSUK Discount: 20% PSUK Discount: 20%
(10% MDS + 10% wholesale) (10% MDS + 10% wholesale)
CHEWABLE
SWALLOWABLE
ONE-A-DAY
NHS list price: Drug Tariff February 2021.
Abbreviated Prescribing Information.
®
Accrete D One-a-Day 1000 mg/880 IU Chewable Tablets & Accrete D Film-Coated Tablets insufficiency. This medicinal product contains aspartame (E951), a source of phenylalanine
®
3
3
which may be harmful for people with phenylketonuria. Interactions: Thiazide diuretics, cardiac
Abbreviated Prescribing Information. Please refer to the appropriate Summary of Product
Characteristics (SmPC) before prescribing Accrete D . Accrete D One-a-Day 1000 mg/880 glycosides, systemic corticosteroids, phenytoin, barbiturates, ion exchange resins, laxatives. Do
3
3
IU Chewable Tablets : Each chewable tablet contains 1000 mg calcium (as 2500 mg calcium
not take calcium within 2 hours of eating foods high in oxalic acid and phytic acid. Administer
®
carbonate) and 880 IU colecalciferol. Contains aspartame (E951), sorbitol (E420), isomalt (E953) tetracycline <2 hours before or 4 to 6 hours after Accrete D 3 . Administer bisphosphonate or
and sucrose. Accrete D Film-Coated Tablets : Contains 600 mg calcium (as calcium carbonate
sodium fluoride at least 3 hours before Accrete D . Do not use levothyroxine within 4 hours
®
3
3
1500 mg) and 10 micrograms of colecalciferol (equivalent to 400 IU vitamin D ) and sucrose. before or after Accrete D . Administer quinolone antibiotics <2 hours before or 6 hours after
3
3
Indication: Prevention and treatment of vitamin D and calcium deficiency in the elderly. Adjunct
Accrete D . Pregnancy and Lactation: During pregnancy, daily dose should not exceed 1500
3
to specific osteoporosis treatment of patients at risk of vitamin D and calcium deficiency. mg calcium and 600 IU vitamin D. Halve tablet if necessary to reduce dose. Suitable for use
during breastfeeding. Calcium and vitamin D pass into breast milk. This should be considered
Dosage and Administration: For oral use. Accrete D One-a-Day: One chewable tablet daily.
3
Accrete D Film-Coated: One tablet twice per day. Contraindications: Hypersensitivity to any when giving additional vitamin D to the child. Undesirable effects: Allergic reactions may be
3
possible. Uncommonly hypercalcaemia or hypercalciuria. Rarely gastro-intestinal disorders, rash,
of the ingredients, hypercalciuria/hypercalcaemia and conditions leading to hypercalciuria/
hypercalcaemia, nephrolithiasis, nephrocalcinosis, hypervitaminosis D, severe renal impairment/ pruritus, urticaria. Legal Category: Accrete D One-a-Day: P; Accrete D Film-Coated: P. Pack
3
3
renal failure. Not for paediatric use. Warnings and Precautions: Monitor serum calcium and size: Accrete D One-a-Day: £2.95 for 30 tablets; Accrete D Film-Coated: £2.95 for 60 tablets.
3
3
creatinine (renal function) in cases of long-term use, concomitant use of cardiac glycosides MA Number: Accrete D One-a-Day: PL04416/1318; Accrete D Film-Coated: PL 40861/0001.
3
3
or thiazide diuretics, or a high tendency to calculus formation. Use caution and monitor Distributor (Accrete One-a-Day)/MA Holder (Accrete D Film-Coated): Internis Pharmaceuticals
3
calcium and phosphate in cases of renal impairment. In cases of hypercalcaemia or impaired Ltd., Linthwaite Laboratories, Linthwaite, Huddersfield, HD7 5QH, UK. Date of preparation:
renal function, reduce the dose or discontinue treatment. Use caution in cases of sarcoidosis, August 2020. Unique ID: ACC-131. ACC-135. DoP: Jan 2021
immobilised patients with osteoporosis. In patients with a history of renal stones, hypercalciuria
should be excluded. Use close medical supervision if prescribing additional calcium or vitamin Adverse events should be reported. Reporting forms and information can be found at:
D via other medicines. Concomitant use of tetracyclines or quinolones is not recommended. Do www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or
not take in case of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase Apple App Store. Adverse events should also be reported to 01484 848164.
For more information contact us on 01484 842 217 or email
bonehealth@thorntonross.com or visit www.thorntonross.com
10:41:23
10:41:23